Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX(®) Modified Release Tablets in Healthy Male and Female Volunteers

The primary objective of this single- and multiple-dose pharmacokinetic study was the investigation of rifamycin SV’s pharmacokinetic profile in plasma and urine. All the 18 enrolled healthy men and post-menopausal women received modified release tablets containing 600 mg of the oral non-absorbable...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Stefano, Andrea Francesco Daniele, Radicioni, Milko Massimiliano, Vaccani, Angelo, Mazzetti, Alessandro, Longo, Luigi Maria, Moro, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915865/
https://www.ncbi.nlm.nih.gov/pubmed/33562091
http://dx.doi.org/10.3390/antibiotics10020167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915865/
https://www.ncbi.nlm.nih.gov/pubmed/33562091
http://dx.doi.org/10.3390/antibiotics10020167

Ejemplares similares